Cargando…
Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials
OBJECTIVE: Serum prokineticin-1 (s-PROK1) in the second and third trimester of pregnancy is positively correlated to preeclampsia, intrauterine growth restriction (IUGR) and preterm delivery. Women with polycystic ovary syndrome (PCOS) are prone to these adverse pregnancy outcomes. However, the cont...
Autores principales: | Ujvari, Dorina, Trouva, Anastasia, Hirschberg, Angelica Lindén, Vanky, Eszter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668301/ https://www.ncbi.nlm.nih.gov/pubmed/37989369 http://dx.doi.org/10.1136/bmjopen-2023-073619 |
Ejemplares similares
-
Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022) -
Vitamin D supplementation prior to in vitro fertilisation in women with polycystic ovary syndrome: a protocol of a multicentre randomised, double-blind, placebo-controlled clinical trial
por: Hu, Kai-Lun, et al.
Publicado: (2020) -
Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis
por: Mousa, Aya, et al.
Publicado: (2020) -
Effects of moxibustion on reproduction and metabolism of polycystic ovary syndrome: a protocol for meta-analysis and systematic review
por: Xu, Kou, et al.
Publicado: (2021) -
Dihydrotestosterone potentiates insulin to up‐regulate prokineticin‐1 in decidualizing human endometrial stromal cells
por: Ujvari, Dorina, et al.
Publicado: (2020)